Occlusive retinal vasculitis and scleritis following brolucizumab treatment: A case report
This case underscores the potential for brolucizumab-induced scleritis and emphasizes the importance of recognizing and promptly managing this complication. Furthermore, it highlights the need for long-term careful follow-up in patients who develop occlusive retinal vasculitis after brolucizumab treatment.
Authors
- Masahiro Miura (ORCID: https://orcid.org/0000-0001-8698-6947)
- Shunpei Onagawa
Institutions
- Tokyo Medical University Ibaraki Medical Center (JP)
Publication Details
- Journal
- Medicine
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1097/md.0000000000040154
- Citations
- 2
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.08
Funders
- Kowa Company
- Santen
- Japan Society for the Promotion of Science